Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single Blind, Placebo Controlled Phase 2 Study to Assess the Safety of ADXS11-001 for the Treatment of Cervical Intraepithelial Neoplasia Grade 2/3

NCT01116245 is registered in ClinicalTrials.gov with Advaxis, Inc. as lead sponsor.

NCT NCT01116245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01116245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single Blind, Placebo Controlled Phase 2 Study to Assess the Safety of ADXS11-001 for the Treatment of Cervical Intraepithelial Neoplasia Grade 2/3
Lead sponsor
Advaxis, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2010
Completion date
April 30, 2016
Enrollment
81 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia